Texas Ventures Acquisition III Corp - Class A Ordinary Share (TVA)
Live price chart, market sentiment, and community perspectives for Texas Ventures Acquisition III Corp - Class A Ordinary Share (NASDAQ: TVA).
Live price chart, market sentiment, and community perspectives for Texas Ventures Acquisition III Corp - Class A Ordinary Share (NASDAQ: TVA).
On our desk, we are watching the valuation closely. With CirclFi models showing 0 out of 5 valuation models projecting upside at $10.50 and a consensus sell rating from analysts, the market sentiment leans heavily bearish. The quality score of 5.4/10 underscores mixed signals, making it a tricky space for speculative capital right now.
Looking at the market positioning in July, short interest for Texas Ventures Acquisition III Corp dropped by a significant 68.9%. While this reduction in short positioning removes some immediate downward pressure, it hasn't translated into bullish momentum, especially with quantitative models sticking to an overvalued consensus.
As a quant monitoring SPAC structures, the underlying trust details remain the anchor. TVA originally raised $225 million and placed $226.1 million into trust at roughly $10.05 per unit. By Q2 2026, trust-driven income was actively posted via Form 10-Q filings, backed by short-term U.S. government securities, which props up the hard asset floor near the current $10.53 trading price.
From a risk management standpoint, TVA's Q1 2026 reporting is hard to ignore. The company flagged a net loss of $472,477 driven by high general and administrative expenses of $2.52 million, alongside a working capital deficiency of $1.76 million. Management itself highlights that being within one year of mandatory liquidation raises substantial doubt about its ongoing operations.
Reviewing the institutional history in the recent 10-K filing, there was a notable sponsor change back in September 2025 and a new insider letter governing voting and indemnity obligations. These structural shifts combined with 22,500,000 Class A shares and 7,500,000 Class B ordinary shares mean we need to watch how management plans to execute a business combination before the clock runs out.
Explore plasma cleansing, somatic organ swaps, and BCI.